ASX:IBXImagion Biosys Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Imagion Biosys Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$0.02MA: A$0.04▼A$0.0552-Week Range N/AVolume3.71 million shsAverage VolumeN/AMarket Capitalization$15.81 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Imagion Biosystems Limited provides tools to detect and eliminate cancer. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company was founded in 1996 and is based in San Diego, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Imagion Biosys. Previous Next 2.8 Community Rank Outperform VotesImagion Biosys has received 10 “outperform” votes. (Add your “outperform” vote.)Underperform VotesImagion Biosys has received 8 “underperform” votes. (Add your “underperform” vote.)Community SentimentImagion Biosys has received 55.56% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Imagion Biosys and other stocks. Vote “Outperform” if you believe IBX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IBX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldImagion Biosys does not currently pay a dividend.Dividend GrowthImagion Biosys does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Imagion Biosys insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Imagion Biosys is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Imagion Biosys is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:IBX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.imagionbiosystems.com/ Phone855-564-5264Debt Debt-to-Equity Ratio29.49 Current Ratio2.78 Quick Ratio2.71Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.49 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.50 Book ValueA$0.01 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares511,281,984Market Cap$15.81 million Next Earnings DateN/A OptionableNot Optionable Receive IBX News and Ratings via Email Sign-up to receive the latest news and ratings for IBX and its competitors with MarketBeat's FREE daily newsletter. Imagion Biosys (ASX:IBX) Frequently Asked Questions Has Imagion Biosys been receiving favorable news coverage? News stories about IBX stock have trended very negative on Tuesday, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Imagion Biosys earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutImagion Biosys. Who are some of Imagion Biosys' key competitors? Some companies that are related to Imagion Biosys include BARD1 Life Sciences (BD1), Lexagene (LXG), Oncimmune (ONC), SQI Diagnostics (SQD), Sernova (SVA), GeneNews (GEN), Deepmatter Group (DMTR), LED Medical Diagnostics (LMD), Genedrive (GDR), Dorsavi (DVL), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), Smiles Inclusive (SIL), Imaging Dynamics (IDL) and Lifespot Health (LSH). What other stocks do shareholders of Imagion Biosys own? Based on aggregate information from My MarketBeat watchlists, some companies that other Imagion Biosys investors own include Pyxus International (PYX), Alibaba Group (BABA), Arcadia Biosciences (RKDA) and Amani Gold (ANL). Who are Imagion Biosys' key executives? Imagion Biosys' management team includes the following people: Mr. Robert Romeo Proulx, Exec. Chairman, Pres & CEO (Age 61)Mr. Brian D. Conn, Chief Financial OfficerMs. Jovanka Naumoska, Company Sec. & Non Exec. DirectorDr. Marie Zhang, Vice-Pres of Research & Pre- Clinical Dev What is Imagion Biosys' stock symbol? Imagion Biosys trades on the ASX under the ticker symbol "IBX." How big of a company is Imagion Biosys? Imagion Biosys has a market capitalization of $0.00 and generates $2.49 million in revenue each year. View additional information about Imagion Biosys. What is Imagion Biosys' official website? The official website for Imagion Biosys is http://www.imagionbiosystems.com/. How can I contact Imagion Biosys? The company can be reached via phone at 855-564-5264. This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: What is meant by a buy rating?
